IL2 and hepatocellular carcinoma: Both in vitro and in vivo studies demonstrated that TT‐LDCP NPs efficiently deliver PD‐L1 siRNA and IL‐2 pDNA into HCC cells with a high transfection efficiency compared to non‐targeted LDCP NPs and TT‐LCP without dendrimer.